公开(公告)号：US12295978B2

公开(公告)日：2025-05-13

申请号：US16967074

申请日：2018-09-28

Applicant: SHIFTBIO INC.

Inventor： Gi-Beom Kim ,  Yoo Soo Yang ,  In-San Kim ,  Gihoon Nam

IPC: A61K35/766 ,  A61K45/06 ,  A61P35/00 ,  C07K16/28

Abstract: The present invention relates to a recombinant plasma membrane-based vesicle, and more specifically to a recombinant plasma membrane-based vesicle comprising a VSV-G mutated protein in which histidine, the 162nd amino acid, has been substituted with arginine, and a pharmaceutical composition for treating cancer comprising the recombinant plasma membrane-based vesicle.